We would love to hear your thoughts about our site and services, please take our survey here.
If you are a sizeable fund manager, how many people are you going to employ to follow and monitor volatile AIM stocks? Is it worth the investment in manpower to do this?
You are more likely to briefly review some interesting RNSs and maybe act only when these show something interesting.
You will concentrate your research efforts on the more mainstream business where there is a wealth of information to guide your decisions.
This is where the PI has an advantage, can focus on the opportunity and reap the outsised benefits by taking a longer view on fundamentals.
Don't knock it, keep loading up until the messiah comes!
Dear Cosy crying 'Wolf' all weekend. Oh dear Costy Wolfy - you need to grow up a little.
Booooorrrrriiiiinnnngggg.
Broken record syndrome!
Looks like today's mantra is not enough exploration, 'new; exploration needed.
Really? So lame.
Something new on the exploration front? Really? Like the RNS just issued on drill results at SWAG. You know, the one that's still warm from being hot off the press.
Do keep up, or try something a little more credible, this one aint working!
There's a few about:
https://twitter.com/susie_dent/status/1634271895288774658?s=20
I still have my bottle ready for the big one. Never lost faith.
Silver, but still good.
yes, but lots of it.
Wasn't there an 18% copper mention also.
Multi metal system, so b fantastic IMO.
Spot on @Timber. Note the number of collars ready for more drilling. They have set out the team play, the next set of results could be really interesting.
Need I say more!
Yup, they are using a nutter filter to drop his connections.
Do keep up. The DFS from NCM is awaited, GGP can't give an update on timelines until NCM produce the DFS. Until then it is the same as per the previous FS.....
Nothing untoward here at all, try something else more credible.
?
It is a ratio, simples. So if 101 units go in, then we have 100 in the tumour, 1 in the bloodstream, simples.
Also it has been RNSed about a therapeutic level in the tumour. Job done.
LOL @Purple1
Delete 'not', replace with 'does mean'.
Interesting. So Newcrest is juggling some of their JVs around Telfer..... Strokes chin knowingly.....
Isn't covered under 'unequavical'
This will be (is) a normal measured progression of a discovery. This is how HAV would have progressed in the absence of NCM.
Rio don't have the financial black hole (Telfer) chasing their behinds to force an accelerated process.
School of 'take a punt' investing.....
Let's all just ignore the company's RNSs and guess!!